✦ LIBER ✦

P148 - Adalimumab maintains long-term remission in patients with moderately to severely active Crohn's disease through 3 years of therapy

✍ Scribed by R. Panaccione; J.F. Colombel; W.J. Sandborn; P. Rutgeerts; G. D'Haens; K.G. Lomax; J. Li; P.F. Pollack

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

922 Adalimumab Maintains Long-Term Remis

✍ Remo Panaccione; Jean-Frédéric Colombel; William J. Sandborn; Paul Rutgeerts; Ge 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 173 KB

920 Adalimumab Maintains Long-Term Remis

✍ Remo Panaccione; William J. Sandborn; Geert D'Haens; Robert A. Enns; Douglas C. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 195 KB

W1092 Maintenance of Long-Term Remission

✍ Rutgeerts, Paul; Colombel, Jean-Frederic; Sandborn, William J.; Rutgeerts, Paul 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Long-term safety and efficacy of adalimu

✍ Watanabe, Mamoru; Hibi, Toshifumi; Mostafa, Nael M.; Chao, Jingdong; Arora, Vipi 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 945 KB

T1012 Long-Term Maintenance of Clinical

✍ Panaccione, Remo; Colombel, Jean-Frederic; Sandborn, William J.; Robinson, Anne; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 182 KB

P083 - Steroid-free remission in patient

✍ M.A. Kamm; S.B. Hanauer; R. Panaccione; J.F. Colombel; W.J. Sandborn; K.G. Lomax 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 62 KB